cro.directory
← Compare landing

ICON vs Tigermed

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/kcrcro/tigermedgrp

CategoryICONTigermed
Listed sitecrocro
SummaryICON is a CRO with 8,000 biotech-dedicated professionals offering end-to-end clinical development, consulting, and therapeutic expertise across all development phases.Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Clinical Imaging Core Lab
  • Central Laboratory Services
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Regulatory Affairs
  • Medical Writing
  • Cardiovascular & Metabolic Specialty Services
  • CNS Specialty Services
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Clinical Imaging Core Lab
  • Central Laboratory Services
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • Device & Combination Product Services
  • Translational Research
  • GLP Toxicology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Medicinal Chemistry
  • High-Throughput Screening
  • Oncology Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • CNS Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • Microbiology Services
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • Cell Therapy
  • Gene Therapy
  • Radiopharmaceutical
  • Oligonucleotide
  • Peptide
Indications
  • Oncology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Women's Health
  • Oncology
  • Cardiovascular
  • Neurology
  • Immunology
  • Infectious Disease
  • Rare Disease
  • Metabolic
  • Ophthalmology
  • Gastroenterology
  • Respiratory
LocationsData not yet provided.
  • Headquarters, Hangzhou, Zhejiang, China
  • Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.